Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medtronic warning letter

This article was originally published in The Gray Sheet

Executive Summary

Firm's Synchromed II and MiniMed Paradigm insulin pumps are subject to a June 1 FDA warning letter. During a Nov. 12-Dec. 15, 2008, inspection of Medtronic's Puerto Rico manufacturing facility, FDA identified quality system violations related to manufacture of the Synchromed devices and medical device reporting violations related to the Paradigm pumps. For example, Synchromed pumps were distributed and implanted in patients without being filled with a necessary propellant, but the firm took nearly two years to conduct a recall. In addition, Medtronic failed to report device-related serious injuries to FDA in a timely manner, the agency charges
Advertisement

Related Content

Medtronic responds to warning letter

Topics

Advertisement
UsernamePublicRestriction

Register

MT027603

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel